128 related articles for article (PubMed ID: 28629732)
1. Impact of granulocyte contamination on PBMC integrity of shipped blood samples: Implications for multi-center studies monitoring regulatory T cells.
Agashe C; Chiang D; Grishin A; Masilamani M; Jones SM; Wood RA; Sicherer SH; Burks AW; Leung DYM; Dawson P; Sampson HA; Berin MC
J Immunol Methods; 2017 Oct; 449():23-27. PubMed ID: 28629732
[TBL] [Abstract][Full Text] [Related]
2. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
3. The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements.
Scheinberg P; Melenhorst JJ; Hill BJ; Keyvanfar K; Barrett AJ; Price DA; Douek DC
J Immunol Methods; 2007 Apr; 321(1-2):107-20. PubMed ID: 17316678
[TBL] [Abstract][Full Text] [Related]
4. CD4+CD25+ T cells expressing FoxP3 in Icelandic horses affected with insect bite hypersensitivity.
Hamza E; Steinbach F; Marti E
Vet Immunol Immunopathol; 2012 Jul; 148(1-2):139-44. PubMed ID: 21700344
[TBL] [Abstract][Full Text] [Related]
5. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
6. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
7. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
8. The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells.
Law JP; Hirschkorn DF; Owen RE; Biswas HH; Norris PJ; Lanteri MC
Cytometry A; 2009 Dec; 75(12):1040-50. PubMed ID: 19845018
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
10. Impact of delayed PBMC processing on functional and genomic assays.
Yi PC; Zhuo L; Lin J; Chang C; Goddard A; Yoon OK
J Immunol Methods; 2023 Aug; 519():113514. PubMed ID: 37353001
[TBL] [Abstract][Full Text] [Related]
11. Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients.
Grant J; Bourcier K; Wallace S; Pan D; Conway A; Seyfert-Margolis V; Wallace PK
Cytometry B Clin Cytom; 2009 Mar; 76(2):69-78. PubMed ID: 18690669
[TBL] [Abstract][Full Text] [Related]
12. Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function.
McKenna KC; Beatty KM; Vicetti Miguel R; Bilonick RA
J Immunol Methods; 2009 Feb; 341(1-2):68-75. PubMed ID: 19041316
[TBL] [Abstract][Full Text] [Related]
13. An imbalance in interleukin-17-producing T and Foxp3⁺ regulatory T cells in women with idiopathic recurrent pregnancy loss.
Lee SK; Kim JY; Hur SE; Kim CJ; Na BJ; Lee M; Gilman-Sachs A; Kwak-Kim J
Hum Reprod; 2011 Nov; 26(11):2964-71. PubMed ID: 21926059
[TBL] [Abstract][Full Text] [Related]
14. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
Hamza E; Gerber V; Steinbach F; Marti E
Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile recurrence is characterized by pro-inflammatory peripheral blood mononuclear cell (PBMC) phenotype.
Yacyshyn MB; Reddy TN; Plageman LR; Wu J; Hollar AR; Yacyshyn BR
J Med Microbiol; 2014 Oct; 63(Pt 10):1260-1273. PubMed ID: 25001105
[TBL] [Abstract][Full Text] [Related]
16. Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C.
Akiyama M; Ichikawa T; Miyaaki H; Motoyoshi Y; Takeshita S; Ozawa E; Miuma S; Shibata H; Taura N; Nakao K
Intervirology; 2010; 53(3):154-60. PubMed ID: 20068349
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
[TBL] [Abstract][Full Text] [Related]
18. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
[TBL] [Abstract][Full Text] [Related]
19. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
20. Is it necessary to deplete the lymphokine activated killers' populations of CD4+CD25+ lymphocytes? Regulatory Foxp3-positive T cells within lymphokine activated killers.
Chikileva IO; Shubina IZ; Baronzio G; Kiselevsky MV
Biomed Pharmacother; 2010 Jul; 64(6):379-85. PubMed ID: 20347251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]